HealthQuill Pharma
Johnson & Johnson plans to acquire Israelā€™s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the US-based company.
Drugs Pharma

Johnson & Johnson ends late-stage trial of depression drug aticaprant

HQ Team March 7, 2025: Johnson & Johnson is discontinuing the Phase 3 VENTURA clinical trial of its experimental depression drug aticaprant after.

Read More
Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latterā€™s technology to discover tissue-targeting molecules.
Drugs Medical Pharma

Novo Nordisk to pay US-based Gensaic $354 million upfront in licensing deal

HQ Team March 5, 2025: Novo Nordisk will pay Gensaic, Inc., a biotechnology company, an upfront payment of $354 million for the latterā€™s.

Read More
Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer's disease, and these abnormal proteins also accumulate in the dying cells in the retina of the eyes of the patients with the condition, investigators at Cedars-Sinai Medical Center found.
Health Pharma Research

Abnormal protein accumulation in patientā€™s eyes linked to Alzheimerā€™s

HQ Team March 4, 2025: Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer’s disease, and these.

Read More
AbbVie Inc. will license a drug to treat obesity from Denmarkā€™s Gurba A/S, a preclinical contract research services and peptide-based drug discovery, for about $2.2 billion to mark its entry into the obesity treatment space.
Drugs Medical Pharma

AbbVie inks $2.2b deal with Denmarkā€™s Gurba, enters weight-loss market

Ā HQ Team March 4, 2025: AbbVie Inc. will license a drug to treat obesity from Denmarkā€™s Gurba A/S, a preclinical contract research services.

Read More
Thermo Fisher Scientific to buy Solvemtumā€™s purification unit for $4.1 billion in cash
Drugs Medical Pharma

Thermo Fisher to buy Solventumā€™s filtration unit for $4.1 billion in cash

HQ Team March 1, 2025: Thermo Fisher Scientific Inc., will buy Solventumā€™s purification and filtration business for $4.1 billion in cash to support.

Read More
Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according to a statement.
Drugs Medical Pharma

Eli Lilly to set up four manufacturing facilities in US for $27 billion

Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.

Read More
AstraZeneca Plc.ā€™s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the Anglo-Swedish company.
Drugs Health Pharma

AstraZeneca says trial breast cancer drug improves survival rates

AstraZeneca Plc.ā€™s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.

Read More
Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats
Drugs Health Pharma

Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats

Eli Lilly and CompanyĀ cut the prices of its weight-loss drugĀ  Zepbound, available in single-dose vials, in a bid to end compounding companies from.

Read More
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency forĀ ResearchĀ on Cancer, aĀ specialisedĀ arm of the WorldĀ HealthĀ Organization.
Drugs Health Pharma

Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns

Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.

Read More
Irelandā€™s Medtronic Plcā€™s deep brain stimulation device for patients with Parkinsonā€™s disease has been approved by the US Food and Drug Administration, according to a company statement.
Health Medical Pharma

Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval

Irelandā€™s Medtronic Plcā€™s deep brain stimulation device for patients with Parkinsonā€™s disease has been approved by the US Food and Drug Administration, according.

Read More